Published: Fri, July 13, 2018
Medical | By Johnnie Horton

Free replacement pill due for 'possibly cancer-causing' drugs

Free replacement pill due for 'possibly cancer-causing' drugs

The valsartan active ingredient from the facility in China has been used by various pharmaceutical manufacturers to produce valsartan-containing medications in Europe, some of which are available on-island. The offending impurity is N-nitrosodimethylamine (NDMA), which has been listed as a probable carcinogen by the International Agency for Research on Cancer.

Health Canada is warning that several drugs containing an ingredient used to treat high blood pressure and prevent heart attacks and strokes are being recalled because they were found to contain a cancer-causing impurity.

The products are sold globally, which has led to a worldwide recall on a country-by-country basis. The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured, the EMA said. The drug regulator for the European Union said it would conduct an assessment of the severity of the problem for those who are now taking drugs containing Valsartan.

A Class 1 Medicines Recall is now underway with all valsartan containing medicines made by Actavis Group and Dexcel Pharma being recalled at a European level as a result of the potential contamination.

Thai boys sedated, stretchered from cave in dramatic rescue
At around 10 p.m., Volanthen emerged from the waters around the mound and shone a torch into the startled eyes of the boys. It was barely days after the Wild Boars were rescued that a Thai cave rescue movie was announced to be in development.

But the agency also said that anyone taking medication that contains valsartan should continue to take it unless told to stop by their doctor or pharmacist.

The Ministry has affirmed that it is always in close coordination and communication with the FDA and the European and Australian Medicines agencies to get any updates and take any necessary actions as soon as possible to protect the health of patients and people in the country.

"Despite the lack of conclusive evidence on whether NDMA is present in these products or whether they are truly unsafe, these measures were undertaken to pre-emptively protect consumers", a spokesman for the Ministry of Food and Drug Safety said on Saturday. Pharmacies are therefore instructed to remove the affected medications from their stock and quarantine them.

Like this: